Rosemont Takes First Steps Outside UK With Acquisition In Greece

Liquids Specialist Acquires Privately-Owned R&D Organization Pharma-Data

Having earlier this year outlined plans for international expansion, liquids specialist Rosemont has made its first venture outside the UK by acquiring Greek R&D organization Pharma-Data.

Handshake with flags of UK and Greece
The UK’s Rosemont has made an acquisition in Greece • Source: Shutterstock

UK liquids specialist Rosemont Pharmaceuticals has delivered on promises to expand outside of its domestic market by striking a deal to acquire privately-owned Greek R&D organization Pharma-Data.

Indicating that the acquisition “enhances [our] ability to develop products for the global market,” Rosemont noted that Pharma-Data specializes in...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

Nexus Faces Five Year Wait On Injectable Minocycline

Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.

Top 10 Drugs Q1 2026: New Sheriff In Town As Mounjaro Unseats Keytruda - Clone - Clone

Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains

test

uygukgigo

 
• By 

More from Business

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success - C8

 
• By 

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success

 
• By 

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.

Top 10 Drugs Q1 2026: New Sheriff In Town As Mounjaro Unseats Keytruda - Clone - Clone

Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains